{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:18:22Z","timestamp":1790342302184,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["seminperinat.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Perinatology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1053\/j.semperi.2015.11.003","type":"journal-article","created":{"date-parts":[[2016,1,4]],"date-time":"2016-01-04T15:49:19Z","timestamp":1451922559000},"page":"12-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Development of prenatal screening\u2014A historical overview"],"prefix":"10.1053","volume":"40","author":[{"given":"Howard","family":"Cuckle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Maymon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semperi.2015.11.003_bib1","first-page":"1323","article-title":"Maternal serum alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of the U.K. Collaborative Study on Alpha-Fetoprotein in Relation to Neural-Tube Defects","volume":"i","author":"Wald","year":"1977","journal-title":"Lancet"},{"key":"10.1053\/j.semperi.2015.11.003_bib2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1471-0528.2000.tb11709.x","article-title":"Maternal serum alphafetoprotein screening for open neural tube defects: revised statistical parameters","volume":"107","author":"Wald","year":"2000","journal-title":"BJOG"},{"key":"10.1053\/j.semperi.2015.11.003_bib3","series-title":"Fetal and Neonatal Neurology and Neurosurgery","first-page":"295","article-title":"Antenatal diagnosis and management of neural tube defects","author":"Cuckle","year":"1995"},{"issue":"3","key":"10.1053\/j.semperi.2015.11.003_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/uog.7329","article-title":"Assessment of intracranial translucency (IT) in the detection of spina bifida at the 11\u201313-week scan","volume":"34","author":"Chaoui","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2015.11.003_bib5","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/uog.8994","article-title":"Retrospective review of diagnostic performance of intracranial translucency in detection of open spina bifida at the 11\u201313-week scan","volume":"38","author":"Fong","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2015.11.003_bib6","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/uog.10111","article-title":"Prospective detection of open spina bifida at 11\u201313 weeks by assessing intracranial translucency and posterior brain","volume":"38","author":"Chaoui","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"10.1053\/j.semperi.2015.11.003_bib7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/uog.12302","article-title":"Cisterna magna width at 11\u201313 weeks in the detection of posterior fossa anomalies","volume":"41","author":"Garcia-Posada","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1053\/j.semperi.2015.11.003_bib8","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/uog.12463","article-title":"Screening for fetal spina bifida at the 11\u201313-week scan using three anatomical features of the posterior brain","volume":"42","author":"Mangione","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2015.11.003_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/pd.2632","article-title":"Posterior brain in fetuses with open spina bifida at 11 to 13 weeks","volume":"31","author":"Lachmann","year":"2011","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2015.11.003_bib10","first-page":"1","article-title":"Brain stem\/brain stem occipital bone ratio and the four-line view in nuchal translucency images of fetuses with open spina bifida","author":"Iuculano","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"4","key":"10.1053\/j.semperi.2015.11.003_bib11","doi-asserted-by":"crossref","first-page":"306.e1","DOI":"10.1016\/j.ajog.2012.05.014","article-title":"Screening for fetal spina bifida by ultrasound examination in the first trimester of pregnancy using fetal biparietal diameter","volume":"207","author":"Bernard","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1053\/j.semperi.2015.11.003_bib12","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/pd.4420","article-title":"Screening for Down syndrome\u2014incidental diagnosis of other aneuploidies","volume":"34","author":"Davis","year":"2014","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2015.11.003_bib13","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/(SICI)1097-0223(199912)19:12<1177::AID-PD714>3.0.CO;2-N","article-title":"Down syndrome fetal loss rate in early pregnancy","volume":"19","author":"Cuckle","year":"1999","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2015.11.003_bib14","series-title":"Genetic Disorders and the Fetus: Diagnosis, Prevention and Treatment","first-page":"771","article-title":"Multianalyte maternal serum screening for chromosomal defects","author":"Cuckle","year":"2010"},{"key":"10.1053\/j.semperi.2015.11.003_bib15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1471-0528.1987.tb03115.x","article-title":"Estimating a woman\u2019s risk of having a pregnancy associated with Down\u2019s syndrome using her age and serum alpha-fetoprotein level","volume":"94","author":"Cuckle","year":"1987","journal-title":"Br J Obstet Gynaecol"},{"issue":"11","key":"10.1053\/j.semperi.2015.11.003_bib16","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/pd.990","article-title":"Age-standardisation when target setting and auditing performance of Down syndrome screening programmes","volume":"24","author":"Cuckle","year":"2004","journal-title":"Prenat Diagn"},{"issue":"12","key":"10.1053\/j.semperi.2015.11.003_bib17","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.7863\/jum.2010.29.12.1741","article-title":"Model predicted performance of second trimester Down syndrome screening with ultrasound prenasal thickness","volume":"29","author":"Miguelez","year":"2010","journal-title":"J Ultrasound Med"},{"key":"10.1053\/j.semperi.2015.11.003_bib18","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/uog.992","article-title":"Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11\u201314-week scan","volume":"23","author":"Cicero","year":"2004","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"7","key":"10.1053\/j.semperi.2015.11.003_bib19","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/pd.4597","article-title":"First trimester screening for Down syndrome using nuchal translucency, maternal serum pregnancy-associated plasma protein A, free-\u03b2 human chorionic gonadotrophin, placental growth factor and \u03b1-fetoprotein","volume":"35","author":"Huang","year":"2015","journal-title":"Prenat Diagn"},{"issue":"9","key":"10.1053\/j.semperi.2015.11.003_bib20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/pd.2557","article-title":"Down syndrome risk calculation for a twin fetus taking account of the nuchal translucency in the co-twin","volume":"30","author":"Cuckle","year":"2010","journal-title":"Prenat Diagn"},{"issue":"1","key":"10.1053\/j.semperi.2015.11.003_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/pd.2643","article-title":"Screening for trisomies in dichorionic twins by measurement of fetal nuchal translucency thickness according to the mixture model","volume":"31","author":"Wright","year":"2011","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2015.11.003_bib22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cll.2010.04.004","article-title":"Additional first-trimester markers","volume":"30","author":"Sonek","year":"2010","journal-title":"Clin Lab Med"},{"issue":"3","key":"10.1053\/j.semperi.2015.11.003_bib23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/uog.1860","article-title":"Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies, results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening","volume":"25","author":"Nicolaides","year":"2005","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1053\/j.semperi.2015.11.003_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/uog.12364","article-title":"Meta-analysis of second-trimester markers for trisomy 21","volume":"41","author":"Agathokleous","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2015.11.003_bib25","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/AOG.0b013e3181c15064","article-title":"Role of second-trimester genetic sonography after Down syndrome screening","volume":"114","author":"Aagaard-Tillery","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"15","key":"10.1053\/j.semperi.2015.11.003_bib26","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.clinbiochem.2015.02.011","article-title":"NIPT for aneuploidy as a clinical service","volume":"48","author":"Cuckle","year":"2015","journal-title":"Clin Biochem"},{"issue":"4","key":"10.1053\/j.semperi.2015.11.003_bib27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/pd.4544","article-title":"Women\u2019s uptake of non-invasive DNA testing following a high-risk screening test for trisomy 21 within a publicly funded healthcare system: findings from a retrospective review","volume":"35","author":"Chan","year":"2015","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2015.11.003_bib28","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/pd.4125","article-title":"Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening","volume":"33","author":"Chetty","year":"2013","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2015.11.003_bib29","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3390\/jcm3030849","article-title":"Impact of cell-free fetal DNA screening on patients\u2019 choice of invasive procedures after a positive california prenatal screen result","volume":"3","author":"Shah","year":"2014","journal-title":"J Clin Med"},{"issue":"10","key":"10.1053\/j.semperi.2015.11.003_bib30","doi-asserted-by":"crossref","first-page":"e109173","DOI":"10.1371\/journal.pone.0109173","article-title":"Non-invasive prenatal chromosomal aneuploidy testing\u2014clinical experience: 100,000 clinical samples","volume":"9","author":"McCullough","year":"2014","journal-title":"PLoS One"},{"key":"10.1053\/j.semperi.2015.11.003_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/uog.14792","article-title":"Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146958 pregnancies","author":"Zhang","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"10.1053\/j.semperi.2015.11.003_bib32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/pd.4123","article-title":"Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples","volume":"33","author":"Futch","year":"2013","journal-title":"Prenat Diagn"},{"issue":"5","key":"10.1053\/j.semperi.2015.11.003_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.08.006","article-title":"Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing","volume":"211","author":"Dar","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"2 Pt 1","key":"10.1053\/j.semperi.2015.11.003_bib34","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/AOG.0000000000000363","article-title":"Single-nucleotide polymorphism-based non-invasive prenatal testing in a high- and low-risk cohort","volume":"124","author":"Pergament","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"332","key":"10.1053\/j.semperi.2015.11.003_bib35","first-page":"e1","article-title":"Expanding the scope of non-invasive prenatal testing: detection of fetal microdeletion syndromes","volume":"212","author":"Wapner","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1053\/j.semperi.2015.11.003_bib36","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/pd.4157","article-title":"Maternal cfDNA screening for Down\u2019s syndrome\u2014a cost sensitivity analysis","volume":"33","author":"Cuckle","year":"2013","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2015.11.003_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pd.3892","article-title":"DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations","volume":"32","author":"Canick","year":"2012","journal-title":"Prenat Diagn"},{"issue":"7","key":"10.1053\/j.semperi.2015.11.003_bib38","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/pd.4132","article-title":"Noninvasive twin zygosity assessment and aneuploidy detection by maternal plasma DNA sequencing","volume":"33","author":"Leung","year":"2013","journal-title":"Prenat Diagn"},{"issue":"5","key":"10.1053\/j.semperi.2015.11.003_bib39","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/uog.12421","article-title":"Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis","volume":"41","author":"Roberge","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2015.11.003_bib40","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.placenta.2010.07.015","article-title":"Screening for pre-eclampsia\u2014lessons from aneuploidy screening","volume":"32","author":"Cuckle","year":"2011","journal-title":"Placenta"},{"issue":"1","key":"10.1053\/j.semperi.2015.11.003_bib41","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000341264","article-title":"Competing risks model in early screening for preeclampsia by biophysical and biochemical markers","volume":"33","author":"Akolekar","year":"2013","journal-title":"Fetal Diagn Ther"},{"key":"10.1053\/j.semperi.2015.11.003_bib42","unstructured":"Svirsky R., Levinson-Tavor O., Feldman N., et al. 2015,Early pregnancy markers of pre-eclampsia in twins. Ultrasound Obstet Gynecol. (in press)"},{"issue":"10","key":"10.1053\/j.semperi.2015.11.003_bib43","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/pd.4402","article-title":"First trimester markers of pre-eclampsia in twins: mean arterial pressure and uterine artery Doppler pulsatility index","volume":"34","author":"Svirsky","year":"2014","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1053\/j.semperi.2015.11.003_bib44","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000345090","article-title":"Maternal serum placental growth factor, pregnancy-associated plasma protein-a and free \u03b2-human chorionic gonadotrophin at 30\u201333 weeks in the prediction of pre-eclampsia","volume":"33","author":"Lai","year":"2013","journal-title":"Fetal Diagn Ther"},{"key":"10.1053\/j.semperi.2015.11.003_bib45","series-title":"Costs of gestational hypertensive disorders in California: hypertension, preeclampsia, and eclampsia","author":"Pourat","year":"2013"},{"issue":"Suppl 1","key":"10.1053\/j.semperi.2015.11.003_bib46","first-page":"e4","article-title":"The impact of aspirin on the prevalence of early onset pre-eclampsia after first trimester screening","volume":"34","author":"Park","year":"2014","journal-title":"Prenat Diagn"},{"issue":"2","key":"10.1053\/j.semperi.2015.11.003_bib47","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000321694","article-title":"Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11\u201313 weeks","volume":"29","author":"Karagiannis","year":"2011","journal-title":"Fetal Diagn Ther"},{"issue":"1","key":"10.1053\/j.semperi.2015.11.003_bib48","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000341712","article-title":"Combined screening for preeclampsia and small for gestational age at 11\u201313 weeks","volume":"33","author":"Poon","year":"2013","journal-title":"Fetal Diagn Ther"},{"issue":"2","key":"10.1053\/j.semperi.2015.11.003_bib49","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000324352","article-title":"Maternal serum \u03b1-fetoprotein at 11\u201313 weeks\u2019 gestation in spontaneous early preterm delivery","volume":"30","author":"Beta","year":"2011","journal-title":"Fetal Diagn Ther"},{"issue":"3","key":"10.1053\/j.semperi.2015.11.003_bib50","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000335686","article-title":"First-trimester screening for spontaneous preterm delivery with maternal characteristics and cervical length","volume":"31","author":"Greco","year":"2012","journal-title":"Fetal Diagn Ther"},{"key":"10.1053\/j.semperi.2015.11.003_bib51","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0002-9378(99)70577-6","article-title":"The performance of routine ultrasonographic screening of pregnancies in the Eurofetus Study","volume":"181","author":"Grandjean","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1053\/j.semperi.2015.11.003_bib52","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/uog.12488","article-title":"Nuchal translucency and major congenital heart defects in fetuses with normal karyotype: a meta-analysis","volume":"42","author":"Sotiriadis","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1053\/j.semperi.2015.11.003_bib53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1469-0705.2002.00735.x","article-title":"How successful is fetal echocardiographic examination in the first trimester of pregnancy","volume":"20","author":"Haak","year":"2002","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2015.11.003_bib54","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/01.AOG.0000250473.99575.72","article-title":"Nuchal translucency and the risk of congenital heart disease","volume":"109","author":"Simpson","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.semperi.2015.11.003_bib55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000314036","article-title":"Ductus venosus in the first trimester: contribution to screening of chromosomal, cardiac defects and monochorionic twin complications","volume":"28","author":"Maiz","year":"2010","journal-title":"Fetal Diagn Ther"},{"key":"10.1053\/j.semperi.2015.11.003_bib56","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1111\/j.1471-0528.2011.03029.x","article-title":"First-trimester ductus venosus screening for cardiac defects: a meta-analysis","volume":"118","author":"Papatheodorou","year":"2011","journal-title":"BJOG"},{"issue":"1","key":"10.1053\/j.semperi.2015.11.003_bib57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/uog.12349","article-title":"First trimester detection of cardiac defects with the use of the ductus venosus blood flow","volume":"42","author":"Borrell","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"14","key":"10.1053\/j.semperi.2015.11.003_bib58","first-page":"00594","article-title":"Risk of selected structural abnormalities in infants after increased nuchal translucency measurement","author":"Baer","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2015.11.003_bib59","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/pd.4194","article-title":"New approaches to first trimester Down\u2019s syndrome screening using additional serum markers and cell free DNA","volume":"33","author":"Johnson","year":"2013","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2015.11.003_bib60","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0092-8674(91)90397-H","article-title":"Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome","volume":"65","author":"Verkerk","year":"1991","journal-title":"Cell"},{"issue":"4","key":"10.1053\/j.semperi.2015.11.003_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta1040","article-title":"Screening for fragile X syndrome","volume":"1","author":"Murray","year":"1997","journal-title":"Health Technol Assess"},{"key":"10.1053\/j.semperi.2015.11.003_bib62","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/pd.1815","article-title":"Preconceptional and prenatal screening for fragile X syndrome: experience with 40,000 tests","volume":"27","author":"Berkenstadt","year":"2007","journal-title":"Prenat Diagn"},{"issue":"8","key":"10.1053\/j.semperi.2015.11.003_bib63","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/ajmg.a.32060","article-title":"Expanded clinical phenotype of women with the FMR1 premutation","volume":"146A","author":"Coffey","year":"2008","journal-title":"Am J Med Genet A"},{"issue":"7","key":"10.1053\/j.semperi.2015.11.003_bib64","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.healthpol.2014.12.016","article-title":"Socio-economic burden of rare diseases: asystematic review of cost of illness evidence","volume":"119","author":"Angelis","year":"2015","journal-title":"Health Policy"},{"issue":"8","key":"10.1053\/j.semperi.2015.11.003_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta3080","article-title":"Screening for cystic fibrosis","volume":"3","author":"Murray","year":"1999","journal-title":"Health Technol Assess"},{"issue":"12","key":"10.1053\/j.semperi.2015.11.003_bib66","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/pd.4459","article-title":"SMA carrier testing: a meta-analysis of differences in test performance by ethnic group","volume":"34","author":"MacDonald","year":"2014","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1053\/j.semperi.2015.11.003_bib67","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000324320","article-title":"Turning the pyramid of prenatal care","volume":"29","author":"Nicolaides","year":"2011","journal-title":"Fetal Diagn Ther"}],"container-title":["Seminars in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000515001573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000515001573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T15:47:01Z","timestamp":1718293621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146000515001573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0146000515001573"],"URL":"https:\/\/doi.org\/10.1053\/j.semperi.2015.11.003","relation":{},"ISSN":["0146-0005"],"issn-type":[{"value":"0146-0005","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of prenatal screening\u2014A historical overview","name":"articletitle","label":"Article Title"},{"value":"Seminars in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semperi.2015.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}